213 related articles for article (PubMed ID: 36629457)
1. The molecular basis of odontogenic cysts and tumours.
Gomes IP; Bastos VC; Guimarães LM; Gomes CC
J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
[TBL] [Abstract][Full Text] [Related]
2. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
[TBL] [Abstract][Full Text] [Related]
3. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of amelogenins in odontogenic epithelial tumours and cysts.
Mori M; Yamada K; Kasai T; Yamada T; Shimokawa H; Sasaki S
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):319-25. PubMed ID: 2024453
[TBL] [Abstract][Full Text] [Related]
5. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
[TBL] [Abstract][Full Text] [Related]
6. Adenoid ameloblastoma harbors beta-catenin mutations.
Bastos VC; Coura BP; Guimarães LM; Fernandes BG; Chan AC; Vargas PA; Bastos-Rodrigues L; De Marco LA; Hellstein J; Thavaraj S; Wright JM; Odell EW; Gomez RS; Gomes CC
Mod Pathol; 2022 Nov; 35(11):1562-1569. PubMed ID: 35840721
[TBL] [Abstract][Full Text] [Related]
7. [BRAF V600E expression in ameloblastomas, ameloblastic carcinomas and cysts].
Pei J; Zhang L; Jia YX; Chen WH
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):630-634. PubMed ID: 38494972
[TBL] [Abstract][Full Text] [Related]
8. Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: Comparative analysis of two VE1 antibodies.
Oh KY; Cho SD; Yoon HJ; Lee JI; Hong SD
J Oral Pathol Med; 2021 Jan; 50(1):85-91. PubMed ID: 32939809
[TBL] [Abstract][Full Text] [Related]
9. Calcifying odontogenic cyst. A review of ninety-two cases with reevaluation of their nature as cysts or neoplasms, the nature of ghost cells, and subclassification.
Hong SP; Ellis GL; Hartman KS
Oral Surg Oral Med Oral Pathol; 1991 Jul; 72(1):56-64. PubMed ID: 1716354
[TBL] [Abstract][Full Text] [Related]
10. Report of Two Cases of Combined Odontogenic Tumors: Ameloblastoma with Odontogenic Keratocyst and Ameloblastic Fibroma with Calcifying Odontogenic Cyst.
Neuman AN; Montague L; Cohen D; Islam N; Bhattacharyya I
Head Neck Pathol; 2015 Sep; 9(3):417-20. PubMed ID: 25552434
[TBL] [Abstract][Full Text] [Related]
11. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
12. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
[TBL] [Abstract][Full Text] [Related]
13. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
[No Abstract] [Full Text] [Related]
14. Whole Exome Sequencing of
Shimura M; Nakashiro KI; Sawatani Y; Hasegawa T; Kamimura R; Izumi S; Komiyama Y; Fukumoto C; Yagisawa S; Yaguchi E; Hitomi-Koide M; Hyodo T; Uchida D; Kawamata H
In Vivo; 2020; 34(6):3233-3240. PubMed ID: 33144428
[TBL] [Abstract][Full Text] [Related]
15. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis.
Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC
Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246
[TBL] [Abstract][Full Text] [Related]
16. The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors.
Guimarães LM; Coura BP; Gomez RS; Gomes CC
Front Oral Health; 2021; 2():740788. PubMed ID: 35048058
[TBL] [Abstract][Full Text] [Related]
17. Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations.
Agaimy A; Skalova A; Franchi A; Alshagroud R; Gill AJ; Stoehr R; Baumhoer D; Bauer S
Histopathology; 2020 May; 76(6):814-821. PubMed ID: 31899815
[TBL] [Abstract][Full Text] [Related]
18. Odontogenic tumors: analysis of 706 cases.
Regezi JA; Kerr DA; Courtney RM
J Oral Surg; 1978 Oct; 36(10):771-8. PubMed ID: 280645
[TBL] [Abstract][Full Text] [Related]
19. Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst.
Cha YH; Cho ES; Kang HE; Ko J; Nam W; Kim HJ; Kim NH; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Nov; 74():62-67. PubMed ID: 29103753
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic signalling pathways in benign odontogenic cysts and tumours.
Diniz MG; Gomes CC; de Sousa SF; Xavier GM; Gomez RS
Oral Oncol; 2017 Sep; 72():165-173. PubMed ID: 28797453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]